Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...
In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...
In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...
The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.
New York, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global In Vitro Toxicology Testing Industry" - https://www ...
A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed ...
NEW YORK CITY, NY, UNITED STATES, February 10, 2025 /EINPresswire.com/ -- Creative Bioarray, a pioneer in providing innovative solutions for biological research and ...
Etelka is a post-doctoral research fellow exploring aerosol science with biology and engineering.View full profile Etelka is a post-doctoral research fellow exploring aerosol science with biology and ...
Addressing for the first time the issue of whether bioequivalence data and in vitro testing can show that an abbreviated new drug application (ANDA) product with different immediate and delayed ...
FOR BIOTECH, DEB, IT REALLY IS. IN THE PAST LEGISLATIVE SESSION, MARYLAND’S GENERAL ASSEMBLY PASSED A BILL PROVIDING GRANTS TO MARYLAND SCIENTISTS WHO DEVELOP NON ANIMAL BASED RESEARCH METHODS. IT WAS ...